Stocks hit all-time highs on optimism about vaccine

Stocks hit all-time highs on optimism about vaccine
Stocks that have been hit hard by lockdowns, like movie theaters and cruise companies, jumped, while stay-at-home companies plunged
NOV 09, 2020
By  Bloomberg

Stocks surged around the world and bonds tumbled after a large-scale coronavirus vaccine study delivered the most-promising results in the battle against the worst pandemic in a century.

More than 85% of S&P 500 companies climbed Monday as the gauge jumped to a record on news that the COVID-19 shot being developed by Pfizer Inc. and BioNTech prevented more than 90% of infections. The enthusiasm also drove the Dow Jones Industrial Average to an all-time high and sparked a rally in small caps.

At 11:10 a.m. New York Time, the S&P 500 was up 2.57% at 3,599.53. The Dow Jones Industrial Average was up 3.76%, or 1,065.95 points, at 29,389.35.

Shares that have been hit hard by the economic toll of lockdowns such as travel stocks and movie theaters jumped, with Carnival Corp. and Cinemark Holdings Inc. surging more than 35%. Stay-at-home companies Zoom Video Communications Inc. and Peloton Interactive Inc. plunged at least 16% on hopes that a return to normal is on the horizon. Online giant Amazon.com Inc. retreated.

A credit derivatives index that measures the perceived risk of high yield dropped by the most in seven months, with junk-rated companies hitting the market in droves to take advantage of a plunge in borrowing costs. Oil soared, while gold, the Japanese yen and the Swiss franc slumped.

Investors pulled out of haven assets and poured cash into markets that are closely tied to economic growth, with a gauge of global stocks also hitting a record high. President-elect Joe Biden Monday announced a new coronavirus task force as his transition team seeks to fulfill a campaign promise to develop a dramatically different approach than President Donald Trump’s to contain the pandemic.

Anthony Fauci, the top infectious disease expert in the U.S., said the vaccine being developed by Pfizer will have a “major impact” on everything we do with regards to the coronavirus going forward.

“The bull market has a ton of ammunition to keep going,” said Chris Larkin, managing director of trading and investing product at ETrade Financial. “With more certainty around the election, a strong quarter of earnings across many sectors, and extremely positive news on the vaccine front, there is little to hold us back.”

More than 85% of S&P 500 members are advancing Monday

Elsewhere, the Australian dollar-yen cross -- a commonly watched risk barometer -- surged by most since June. The Turkish lira soared after the weekend resignation of the country’s economy czar and the dismissal of the central bank chief.

Latest News

The power of cultivating personal connections
The power of cultivating personal connections

Relationships are key to our business but advisors are often slow to engage in specific activities designed to foster them.

A variety of succession options
A variety of succession options

Whichever path you go down, act now while you're still in control.

'I’ll never recommend bitcoin,' advisor insists
'I’ll never recommend bitcoin,' advisor insists

Pro-bitcoin professionals, however, say the cryptocurrency has ushered in change.

LPL raises target for advisors’ bonuses for first time in a decade
LPL raises target for advisors’ bonuses for first time in a decade

“LPL has evolved significantly over the last decade and still wants to scale up,” says one industry executive.

What do older Americans have to say about long-term care?
What do older Americans have to say about long-term care?

Survey findings from the Nationwide Retirement Institute offers pearls of planning wisdom from 60- to 65-year-olds, as well as insights into concerns.

SPONSORED The future of prospecting: Say goodbye to cold calls and hello to smart connections

Streamline your outreach with Aidentified's AI-driven solutions

SPONSORED A bumpy start to autumn but more positives ahead

This season’s market volatility: Positioning for rate relief, income growth and the AI rebound